DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Abortion Induced - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abortion Induced (33)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) where reactions include abortion induced. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 33   Next >>

Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient: 36 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Epivir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiviral Treatment

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: 36 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Epivir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Norvir
    Dosage: daily
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy

Viread
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-23

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Cytogenetic Abnormality, Brain Malformation, Spina Bifida, Abortion Induced, Vertical Talus

Adverse event resulted in: death

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Isentress
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-16

Patient: female

Reactions: Oligohydramnios, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-24



Possible Reyataz side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: 30 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: Antiviral Treatment

Reyataz
    Administration route: Oral
    Indication: Antiviral Treatment

Truvada
    Administration route: Oral
    Indication: Antiviral Treatment



Possible Reyataz side effects in 26 year old female

Reported by a physician from United States on 2012-08-07

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-06

Patient: female

Reactions: Oligohydramnios, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: 1 film coated tablet daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-01-24

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-24



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 38 year old female

Reported by a consumer/non-health professional from France on 2012-05-23

Patient: 38 year old female

Reactions: Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2005-10-01

Reyataz
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy

Truvada
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2005-10-01



Possible Reyataz side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-21

Patient: 42 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2012-02-01

Raltegravir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-02-01

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-09

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-03

Patient: 30 year old female

Reactions: Abortion Induced

Drug(s) suspected as cause:
Norvir
    Dosage: 100 mg/kg/hr
    Administration route: Oral
    Indication: Antiviral Treatment

Reyataz
    Dosage: 300 mg/kg/hr
    Administration route: Oral
    Indication: Antiviral Treatment

Truvada
    Administration route: Oral
    Indication: Antiviral Treatment



Possible Reyataz side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30

Patient: 37 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy

Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-26

Patient: 26 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-11-21

Norvir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25

Patient: 24 year old female

Reactions: Abortion Induced, Pregnancy, Placental Chorioangioma

Drug(s) suspected as cause:
Emtricitabine and Tenofovir Disoproxil Fumarate
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: HIV Infection

Reyataz
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-10-04

Ritonavir
    Dosage: unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-10-04



Possible Reyataz side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25

Patient: 26 year old female

Reactions: Prenatal Screening Test Abnormal, Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Dosage: 2tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Raltegravir
    Dosage: 800mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-09

Patient: 42 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Kaletra
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2012-02-01

Raltegravir
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-02-01

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01

Tenofovir Disoproxil Fumarate
    Administration route: Oral
    Indication: Antiretroviral Therapy
    End date: 2011-10-01



Possible Reyataz side effects in 38 year old female

Reported by a physician from France on 2012-02-22

Patient: 38 year old female

Reactions: Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: no of courses:1

Reyataz
    Dosage: no of courses:1

Truvada
    Dosage: no of courses:1



Possible Reyataz side effects in 38 year old female

Reported by a consumer/non-health professional from France on 2012-02-22

Patient: 38 year old female

Reactions: Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy

Truvada
    Dosage: no of courses:1
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in 38 year old female

Reported by a consumer/non-health professional from France on 2012-02-19

Patient: 38 year old female

Reactions: Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy

Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy



Possible Reyataz side effects in female

Reported by a physician from France on 2012-02-16

Patient: female

Reactions: Congenital Central Nervous System Anomaly, Foetal Exposure During Pregnancy, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14

Patient:

Reactions: Foetal Exposure During Pregnancy, Abortion Induced, Skull Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Ritonavir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-02-10

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-10

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient:

Reactions: Foetal Exposure During Pregnancy, Abortion Induced, Skull Malformation

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Ritonavir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-26

Patient:

Reactions: Foetal Exposure During Pregnancy, Skull Malformation, Abortion Induced

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Ritonavir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-23

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-18

Patient: 38 year old female

Reactions: Maternal Exposure During Pregnancy, Abortion Induced, Pregnancy

Drug(s) suspected as cause:
Norvir
    Administration route: Oral
    Indication: Antiretroviral Therapy

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy

Truvada
    Administration route: Oral
    Indication: Antiretroviral Therapy



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017